Literature DB >> 26479993

Fatigue in Children With Sickle Cell Disease: Association With Neurocognitive and Social-Emotional Functioning and Quality of Life.

Lindsay M Anderson1, Taryn M Allen, Courtney D Thornburg, Melanie J Bonner.   

Abstract

Children with sickle cell disease (SCD) report fatigue in addition to acute and chronic pain, which can decrease overall health-related quality of life (HRQL). The primary objective of the current study was to investigate the relationship between fatigue and HRQL. Given limited prior research, secondary objectives included investigation of associations between fatigue and functional outcomes, including child neurocognitive and social-emotional functioning. Children aged 8 to 16 years (N=32) and a caregiver completed measures of fatigue, HRQL, pain, and neurocognitive and social-emotional functioning. Controlling for pain and number of SCD-related hospitalizations, hierarchical linear regression models were used to determine the impact of child-reported and parent-reported fatigue on child HRQL. Correlational analyses were used to explore the relationship between fatigue and additional child outcomes. Data indicated that children with SCD experience clinically relevant levels of fatigue, which independently predicts lower HRQL. Fatigue was also associated with lower working memory, executive functioning, and higher levels of internalizing symptoms. Given its observed impact on HRQL and relationship to functional outcomes, fatigue may be an important target of clinical, home, or school interventions. This practice may attenuate the burden of fatigue in these patients, and in turn, help improve the quality of life of children living with SCD.

Entities:  

Mesh:

Year:  2015        PMID: 26479993     DOI: 10.1097/MPH.0000000000000431

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  10 in total

1.  Higher executive abilities following a blood transfusion in children and young adults with sickle cell disease.

Authors:  Anna M Hood; Allison A King; Melanie E Fields; Andria L Ford; Kristin P Guilliams; Monica L Hulbert; Jin-Moo Lee; Desiree A White
Journal:  Pediatr Blood Cancer       Date:  2019-07-03       Impact factor: 3.167

2.  Health-Related Quality of Life and Personal Life Goals of Adults With Sickle Cell Disease After Hematopoietic Stem Cell Transplantation.

Authors:  Agatha M Gallo; Crystal Patil; Tokunbo Adeniyi; Lewis L Hsu; Damiano Rondelli; Santosh Saraf
Journal:  West J Nurs Res       Date:  2018-04-06       Impact factor: 1.967

3.  Vitamin D Supplementation Improves Health-Related Quality of Life and Physical Performance in Children with Sickle Cell Disease and in Healthy Children.

Authors:  Kelly A Dougherty; Joan I Schall; Chiara Bertolaso; Kim Smith-Whitley; Virginia A Stallings
Journal:  J Pediatr Health Care       Date:  2020-06-05       Impact factor: 1.812

4.  Responsiveness of PROMIS® Pediatric Measures to Hospitalizations for Sickle Pain and Subsequent Recovery.

Authors:  Carlton Dampier; Byron Jaeger; Heather E Gross; Vaughn Barry; Lloyd Edwards; Yang Lui; Darren A DeWalt; Bryce B Reeve
Journal:  Pediatr Blood Cancer       Date:  2016-02-08       Impact factor: 3.167

5.  Nocturnal Enuresis in Sickle Cell: Sociodemographic, Medical, and Quality of Life Factors.

Authors:  Jerlym S Porter; Andrew J Paladino; Kathryn Russell; Rebecca Rupff; Jamilla Griffith; Yujiao Mai; Hui Zhang; Jane S Hankins; Winfred C Wang
Journal:  J Pediatr Psychol       Date:  2022-02-03

6.  Revisiting anemia in sickle cell disease and finding the balance with therapeutic approaches.

Authors:  Julia Zhe Xu; Swee Lay Thein
Journal:  Blood       Date:  2022-05-19       Impact factor: 25.476

Review 7.  Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease.

Authors:  Anna M Hood; Lori E Crosby; Hanne Stotesbury; Melanie Kölbel; Fenella J Kirkham
Journal:  Front Neurol       Date:  2022-06-21       Impact factor: 4.086

8.  Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease.

Authors:  Deborah Lubeck; Irene Agodoa; Nickhill Bhakta; Mark Danese; Kartik Pappu; Robin Howard; Michelle Gleeson; Marc Halperin; Sophie Lanzkron
Journal:  JAMA Netw Open       Date:  2019-11-01

9.  Development and validation of the sickle cell stress scale-adult.

Authors:  Wally R Smith; Donna K McClish; Viktor E Bovbjerg; Harjot K Singh
Journal:  Eur J Haematol       Date:  2022-06-03       Impact factor: 3.674

Review 10.  Disease burden and quality of life of in children with sickle cell disease in Italy: time to be considered a priority.

Authors:  Raffaella Colombatti; Maddalena Casale; Giovanna Russo
Journal:  Ital J Pediatr       Date:  2021-07-29       Impact factor: 2.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.